Lensar (LNSR) Income from Continuing Operations (2019 - 2026)
Lensar (LNSR) reported Income from Continuing Operations of 2239000.0 for Q1 2026, up 138.67% year-over-year from 938114.91 in Q1 2025, and up 145.52% on a QoQ basis from 4919000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Income from Continuing Operations data on file, last reported at 2239000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 138.67% year-over-year to 2239000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16549000.0 (down 21.64% YoY) and the FY2025 annual result came in at 24578000.0, down 130.45% from the prior year.
- Income from Continuing Operations climbed to 2239000.0 in Q1 2026 per LNSR's latest filing, from 4919000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2239000.0 in Q1 2026 and bottomed at 7580000.0 in Q3 2025.
- The 5-year median for Income from Continuing Operations is 4083000.0 (2022), against an average of 3847647.06.
- The widest annual swing landed in 2025, when Income from Continuing Operations tumbled 508.84%; it then soared 138.67% in 2026.
- Tracing LNSR's Income from Continuing Operations over 5 years: stood at 2613000.0 in 2022, then declined by 13.32% to 2961000.0 in 2023, then soared by 56.43% to 1290000.0 in 2024, then slumped by 281.32% to 4919000.0 in 2025, then jumped by 145.52% to 2239000.0 in 2026.
- Per Business Quant, the three latest LNSR Income from Continuing Operations figures stand at 2239000.0 (Q1 2026), 4919000.0 (Q4 2025), and 7580000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 2.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | -4.92 Mn |
| Sep 30, 2025 | -7.58 Mn |
| Jun 30, 2025 | -6.29 Mn |
| Mar 31, 2025 | -5.79 Mn |
| Dec 31, 2024 | -1.29 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -5.28 Mn |
| Mar 31, 2024 | -2.85 Mn |
| Dec 31, 2023 | -2.96 Mn |
| Sep 30, 2023 | -2.04 Mn |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -4.36 Mn |
| Dec 31, 2022 | -2.61 Mn |
| Sep 30, 2022 | -4.08 Mn |
| Jun 30, 2022 | -6.80 Mn |
| Mar 31, 2022 | -6.68 Mn |
| Dec 31, 2021 | -3.91 Mn |
| Sep 30, 2021 | -6.17 Mn |
| Jun 30, 2021 | -4.38 Mn |
| Mar 31, 2021 | -5.20 Mn |
| Dec 31, 2020 | -6.85 Mn |
| Sep 30, 2020 | -4.78 Mn |
| Jun 30, 2020 | -4.51 Mn |
| Mar 31, 2020 | -3.70 Mn |
| Dec 31, 2019 | -2.49 Mn |
| Sep 30, 2019 | -5.83 Mn |